基于四个欧盟国家七个人口医疗数据库的流感、人乳头瘤病毒和含麻疹成分疫苗年龄别接种覆盖率估计——ADVANCE项目
ADVANCE项目通过分布式网络方法,利用意大利、西班牙、英国和丹麦七个电子医疗数据库,对2006年出生队列的含麻疹成分疫苗、1990-2000年出生队列的人乳头瘤病毒疫苗和1920-1950年出生队列的流感疫苗进行回顾性动态队列研究,采用时期患病率和逆概率加权法估计年龄别接种覆盖率。研究共纳入含麻疹成分疫苗274,616人、人乳头瘤病毒疫苗2,011,666人和流感疫苗14,904,033人,获得了详细的年龄别覆盖率估计,并讨论了数据库间及与已发表国家估计值的可比性。
要点
- 含麻疹成分疫苗第一剂覆盖率84.3%(丹麦)至96.5%(意大利Val Padana),第二剂82.8%(意大利Val Padana)至90.9%(英国)。
- 人乳头瘤病毒疫苗覆盖率(1997-2000年出生队列汇总)15岁时为60%(英国)至88.3%(丹麦)。
- 2009-2015年流感季≥65岁人群流感疫苗覆盖率丹麦约43%、英国约68%保持稳定,西班牙加泰罗尼亚从58%降至50%。
核心结论
- 通过统一流程获得了详细的年龄别覆盖率估计,并讨论了数据库间可比性及与已发表国家估计值的可比性。
研究设计与样本
- 回顾性动态队列研究,采用分布式网络方法,由数据库访问提供者提取数据、转换为通用结构并在本地运行R脚本,输出表在中央服务器共享和合并。
主要发现
- 含麻疹成分疫苗第一剂覆盖率从84.3%(丹麦)到96.5%(意大利Val Padana)不等,第二剂从82.8%(意大利Val Padana)到90.9%(英国)不等(7岁时)。
- 人乳头瘤病毒疫苗覆盖率(1997-2000年出生队列汇总)15岁时从60%(英国)到88.3%(丹麦)不等。
- 2009-2015年流感季≥65岁人群流感疫苗覆盖率丹麦约43%、英国约68%保持稳定,西班牙加泰罗尼亚从58%降至50%。
- 总研究人群:含麻疹成分疫苗274,616人,人乳头瘤病毒疫苗2,011,666人,流感疫苗14,904,033人。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public-private collaboration aiming to develop and test a system for rapid benefit-risk monitoring of vaccines using existing healthcare databases in Europe. We estimated vaccine coverage from electronic healthcare databases as part of a fit-for-purpose assessment for vaccine benefit-risk studies. METHODS: A retrospective dynamic cohort study was conducted through a distributed network approach. Coverage with measles-vaccine for birth year 2006, human papillomavirus (HPV)-vaccine for birth years 1990-2000 and influenza-vaccine for birth years 1920-1950 was estimated using period-prevalence and inverse probability weighting methods. Seven databases from four countries participated: Italy (Pedianet, Val Padana), Spain (BIFAP, SIDIAP), UK (RCGP-RSC, THIN), Denmark (SSI/AUH). Database access providers extracted the data, transformed it into a common structure and ran an R-script locally. The created output tables were shared and pooled at a central server. RESULTS: The total study population comprised 274,616 persons for measles-vaccine, 2,011,666 persons for HPV-vaccine and 14,904,033 persons for influenza-vaccine. Measles-vaccine coverage varied from 84.3% (Denmark) to 96.5% (Italy, Val Padana) for the first dose and from 82.8% (Italy, Val Padana) to 90.9% (UK) for the second dose at the age of 7 years. The HPV-vaccine coverage, aggregated over birth years 1997-2000, ranged from 60% (UK) to 88.3% (Denmark) at the age of 15 years. The influenza-vaccine coverage for the influenza seasons from 2009 to 2015 for persons aged 65 years and more was roughly stable around 43% in Denmark and around 68% in the UK while a decrease from 58 to 50% was observed in Catalonia (Spain). CONCLUSIONS: We obtained detailed, age-specific coverage estimates though a common procedure. We discussed between database comparability and comparability to published national estimates.
引用
- Braeye T, Emborg HD, Llorente-García A, et al. Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project. Vaccine. 2020. PMID: 32171573. doi:10.1016/j.vaccine.2020.02.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。